GINA CHESTER: Open Payments
NPI 1851085625 · JENKINTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 11 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $0 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $147 |
| Incyte Corporation | 1 | $130 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| Lilly USA, LLC | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $120 |
| Janssen Scientific Affairs, LLC | 1 | $33 |
| Alkermes, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: Auvelity, Jakafi, INGREZZA, ZEPBOUND, CAPLYTA, SPRAVATO, LYBALVI, VRAYLAR.
Industry payments across PA — which companies pay providers there.
